• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Dx Deal Roundup: Top 10 Clinical Lab M&A Deals of 2023

Dx Deal Roundup: Top 10 Clinical Lab M&A Deals of 2023

by Glenn S. Demby | Jan 9, 2024 | Deals-lir, Essential, Lab Industry Advisor

An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Roche & Quest Establish Toeholds in Emerging Alzheimer’s Blood Testing Market

Roche & Quest Establish Toeholds in Emerging Alzheimer’s Blood Testing Market

by Glenn S. Demby | Nov 29, 2023 | Deals-lir, Essential, Lab Industry Advisor

While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deal Roundup: A Major Proteomics Merger, Ginkgo Makes Pharma Inroads, and More Legal Woes for Illumina

Dx Deal Roundup: A Major Proteomics Merger, Ginkgo Makes Pharma Inroads, and More Legal Woes for Illumina

by Glenn S. Demby | Oct 24, 2023 | Deals-lir, Essential, Lab Compliance Advisor, Laboratory Industry Report, National Lab Reporter

As is usual at this time of year, deals in the diagnostics industry were up, both in terms of volume and value.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Lab Companies Team with Nonprofits on Test Development, Access, & Awareness

Lab Companies Team with Nonprofits on Test Development, Access, & Awareness

by Glenn S. Demby | May 4, 2023 | Deals-lir, Essential, Laboratory Industry Report

April was among the busiest months, in recent memory, in terms of both deal volume and significance in the diagnostics industry.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Partnership to Create New Tool for Rapid SARS-CoV-2 Variant Detection

Partnership to Create New Tool for Rapid SARS-CoV-2 Variant Detection

by Glenn S. Demby | Mar 31, 2022 | Articles, Deals-lir, Essential, Laboratory Industry Report

Thermo Fisher, Helix, and Rosalind collaborate on an NIH-supported project to develop a new genotyping method to ID virus variants faster.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com